Skip to main content

Our Science Impacts Lives

Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.

$28 million

invested by AbbVie locally in clinical research funding annually

Therapeutic Focus Areas

Researching Areas of Unmet Medical
Need

We’re constantly finding new ways to address patients’ most serious health issues. We concentrate our efforts on a core set of therapeutic areas—ones where we’ve proven our expertise, and where we feel we can have an even greater impact on disease and how it is managed.

Explore

Where We Research

Eight State-of-the-Art R&D Centers:

Lake County, Illinois, US
Redwood City, California, US
Sunnyvale, California, US (Pharmacyclics)
South San Francisco, California, US
Cambridge, Massachusetts, US
Worcester, Massachusetts, US
Ludwigshafen, Germany
Tokyo, Japan

Our Products

A Portfolio of Medicines

We aim to develop innovative therapies for health conditions where there is a significant need. Our medicines are approved by the Therapeutic Goods Administration (TGA) for use in Australia.

Explore

Pipeline

Devoted to New Discoveries

Our scientists are advancing a pipeline of specialty medicines with a focus on cancer, immune-mediated conditions, neurodegenerative diseases and more.

Explore opens in a new window

Clinical Trials

Advancing Medical Knowledge

We have investigational compounds in development within each of our therapeutic areas. A critical component of medicinal product development is clinical research, which involves conducting clinical trials to evaluate the safety and efficacy of new therapies.

Explore

Discovering and developing therapies that have the potential to transform the standard of care for people battling serious and often life-threatening illnesses is our core mission.

Michael Severino, M.D, Executive Vice President, R&D and Chief Scientific Officer